Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-013817

Chief Legal Officer sold 521 shares at $2.77 ($1,445)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robertson Jenny Chief Legal Officer 2025-05-16 Sale −521 $2.77 $1,445 63,098 D
Open-market sales · 521 sh · avg $2.77 · $1,445
Loading xslF345X05/form4-05202025_050504.xml…